$NXTC
NextCure, Inc.

2021 Q4 Form 10-Q Financial Statement

#000155837021014632 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.807M $4.911M $4.660M
YoY Change 16.39% 5.39% 77.86%
% of Gross Profit
Research & Development $12.26M $13.60M $12.74M
YoY Change 1.27% 6.73% 47.11%
% of Gross Profit
Depreciation & Amortization $2.103M $2.096M $880.0K
YoY Change 112.42% 138.18% 12.82%
% of Gross Profit
Operating Expenses $17.07M $18.51M $17.40M
YoY Change 5.12% 6.37% 54.11%
Operating Profit -$18.51M -$17.40M
YoY Change 6.37%
Interest Expense $132.0K $578.0K $1.030M
YoY Change -83.08% -43.88% -18.9%
% of Operating Profit
Other Income/Expense, Net $578.0K $1.032M
YoY Change -43.99%
Pretax Income -$16.94M -$17.93M -$16.37M
YoY Change 9.57% 9.53% 94.19%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$16.94M -$17.93M -$16.37M
YoY Change 9.57% 9.55% 94.15%
Net Earnings / Revenue
Basic Earnings Per Share -$0.65 -$0.59
Diluted Earnings Per Share -$607.3K -$0.65 -$0.59
COMMON SHARES
Basic Shares Outstanding 27.63M 27.62M 27.55M
Diluted Shares Outstanding 27.62M 27.55M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $219.6M $235.3M $291.2M
YoY Change -22.53% -19.18% 58.17%
Cash & Equivalents $12.34M $36.66M $26.46M
Short-Term Investments $207.3M $198.7M $268.7M
Other Short-Term Assets $8.226M $7.700M $5.800M
YoY Change 82.8% 32.76% 13.73%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $227.8M $243.0M $297.0M
YoY Change -20.89% -18.17% 57.06%
LONG-TERM ASSETS
Property, Plant & Equipment $13.99M $14.21M $15.80M
YoY Change -11.49% -10.08% 31.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $577.0K $581.0K $3.300M
YoY Change -79.8% -82.39% -15.38%
Total Long-Term Assets $14.57M $14.79M $19.10M
YoY Change -21.95% -22.57% 19.38%
TOTAL ASSETS
Total Short-Term Assets $227.8M $243.0M $297.0M
Total Long-Term Assets $14.57M $14.79M $19.10M
Total Assets $242.4M $257.8M $316.1M
YoY Change -20.96% -18.44% 54.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.942M $2.946M $200.0K
YoY Change -50.22% 1373.0% -92.31%
Accrued Expenses $4.449M $4.232M $3.800M
YoY Change -3.85% 11.37% 46.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $1.700M
YoY Change -100.0% -100.0% 30.77%
Total Short-Term Liabilities $6.608M $7.376M $5.700M
YoY Change -36.0% 29.4% -54.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.200M
YoY Change -100.0% -100.0% -42.11%
Other Long-Term Liabilities $2.392M $2.223M $800.0K
YoY Change 199.0% 177.88% -95.58%
Total Long-Term Liabilities $2.392M $2.223M $3.000M
YoY Change 32.45% -25.9% -86.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.608M $7.376M $5.700M
Total Long-Term Liabilities $2.392M $2.223M $3.000M
Total Liabilities $9.000M $9.599M $8.700M
YoY Change -30.36% 10.33% -74.78%
SHAREHOLDERS EQUITY
Retained Earnings -$187.0M -$170.1M
YoY Change 58.99%
Common Stock $28.00K $28.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $233.4M $248.2M $307.3M
YoY Change
Total Liabilities & Shareholders Equity $242.4M $257.8M $316.1M
YoY Change -20.96% -18.44% 54.12%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$16.94M -$17.93M -$16.37M
YoY Change 9.57% 9.55% 94.15%
Depreciation, Depletion And Amortization $2.103M $2.096M $880.0K
YoY Change 112.42% 138.18% 12.82%
Cash From Operating Activities -$13.45M -$12.66M -$15.68M
YoY Change 114.5% -19.25% 97.48%
INVESTING ACTIVITIES
Capital Expenditures -$825.0K -$556.0K -$1.870M
YoY Change -15.82% -70.27% 281.63%
Acquisitions
YoY Change
Other Investing Activities -$10.18M $14.97M $14.98M
YoY Change -158.22% -0.07% -108.6%
Cash From Investing Activities -$11.00M $14.41M $13.11M
YoY Change -166.71% 9.95% -107.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 123.0K -2.630M -370.0K
YoY Change -130.75% 610.81% 236.36%
NET CHANGE
Cash From Operating Activities -13.45M -12.66M -15.68M
Cash From Investing Activities -11.00M 14.41M 13.11M
Cash From Financing Activities 123.0K -2.630M -370.0K
Net Change In Cash -24.33M -878.0K -2.940M
YoY Change -347.73% -70.14% -98.39%
FREE CASH FLOW
Cash From Operating Activities -$13.45M -$12.66M -$15.68M
Capital Expenditures -$825.0K -$556.0K -$1.870M
Free Cash Flow -$12.62M -$12.11M -$13.81M
YoY Change 138.64% -12.34% 85.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#TechnologyServiceMember
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27615038
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27547737
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27607685
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27524350
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001661059
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27568802
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27619763
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27615038
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27547737
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27607685
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27524350
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.77
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38905
dei Entity Registrant Name
EntityRegistrantName
NextCure, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5231247
dei Entity Address Address Line1
EntityAddressAddressLine1
9000 Virginia Manor Road
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Beltsville
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20705
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
399-4900
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
NXTC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27626227
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36664000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32772000
CY2021Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
198672000
CY2020Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
250676000
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
39000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1706000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7661000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2824000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
243036000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
287978000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14208000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15809000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
581000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2857000
CY2021Q3 us-gaap Assets
Assets
257825000
CY2020Q4 us-gaap Assets
Assets
306644000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2946000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3901000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4232000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4627000
CY2021Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
198000
CY2020Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
130000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1667000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7376000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10325000
CY2021Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2223000
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
792000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1806000
CY2021Q3 us-gaap Liabilities
Liabilities
9599000
CY2020Q4 us-gaap Liabilities
Liabilities
12923000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27619763
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27568802
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
28000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
28000
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
418414000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
410551000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-129000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
779000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170087000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117637000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
248226000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
293721000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
257825000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
306644000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22378000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13597000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12740000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37928000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34448000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4911000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17864000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17004000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53358000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19844000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
293721000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4659000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15766000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12918000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
18508000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
17399000
us-gaap Operating Expenses
OperatingExpenses
53694000
us-gaap Operating Expenses
OperatingExpenses
47366000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-18508000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-17399000
us-gaap Operating Income Loss
OperatingIncomeLoss
-53694000
us-gaap Operating Income Loss
OperatingIncomeLoss
-24988000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
578000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1032000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1244000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3846000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17930000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-16367000
us-gaap Net Income Loss
NetIncomeLoss
-52450000
us-gaap Net Income Loss
NetIncomeLoss
-21142000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27615038
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27547737
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27607685
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27524350
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17930000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-16367000
us-gaap Net Income Loss
NetIncomeLoss
-52450000
us-gaap Net Income Loss
NetIncomeLoss
-21142000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
66000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-637000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-908000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1298000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2508000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
63000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2021Q1 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-600000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-16533000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
279159000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2787000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1675000
CY2021Q2 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-374000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17987000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
263598000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2483000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2021Q3 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
66000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17930000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
248226000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
321484000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1008000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
37000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2020Q1 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-505000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
9733000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
331757000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2187000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2020Q2 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
2478000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-14508000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
321917000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2372000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
54000
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0
CY2020Q3 nxtc Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Adjusted
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTaxAdjusted
-637000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-16367000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
307339000
us-gaap Profit Loss
ProfitLoss
-52450000
us-gaap Profit Loss
ProfitLoss
-21142000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5093000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2423000
us-gaap Share Based Compensation
ShareBasedCompensation
7778000
us-gaap Share Based Compensation
ShareBasedCompensation
5567000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4365000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
690000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-955000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-395000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1117000
nxtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
1499000
nxtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
336000
nxtc Increase Decrease In Deferred Revenue From Related Party
IncreaseDecreaseInDeferredRevenueFromRelatedParty
-22378000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-43795000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38676000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
171037000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
129169000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
121900000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
95992000
CY2020Q4 nxtc Restricted Cash Other Assets Non Current
RestrictedCashOtherAssetsNonCurrent
1806000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1535000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6152000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
47602000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27025000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
85000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94000
us-gaap Repayments Of Debt
RepaymentsOfDebt
3473000
us-gaap Repayments Of Debt
RepaymentsOfDebt
1111000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3388000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1017000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
419000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12668000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36284000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39130000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36703000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26462000
us-gaap Interest Paid Net
InterestPaidNet
139000
us-gaap Interest Paid Net
InterestPaidNet
130000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
134000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of assets and liabilities as of the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting periods. Although actual results could differ from those estimates, management does not believe that such differences would be material.</p>
CY2021Q3 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-2400000
CY2021Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
5000000.0
CY2021Q3 nxtc Restricted Cash Other Assets Non Current
RestrictedCashOtherAssetsNonCurrent
0
CY2021Q3 nxtc Required Reserve Restricted Cash Current
RequiredReserveRestrictedCashCurrent
0
CY2020Q4 nxtc Required Reserve Restricted Cash Current
RequiredReserveRestrictedCashCurrent
3500000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36664000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32772000
CY2021Q3 nxtc Restricted Cash Other Assets Non Current
RestrictedCashOtherAssetsNonCurrent
0
CY2021Q3 nxtc Restricted Cash And Other Assets Current
RestrictedCashAndOtherAssetsCurrent
39000
CY2020Q4 nxtc Restricted Cash And Other Assets Current
RestrictedCashAndOtherAssetsCurrent
3512000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36703000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36284000
CY2021Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
198801000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
43000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
172000
CY2021Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
198672000
CY2020Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
249897000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
854000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
75000
CY2020Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
250676000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
57000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
70000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
96103000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
96114000
CY2021Q3 nxtc Available For Sale Securities Debt Maturities After One Through Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsAmortizedCost
102698000
CY2021Q3 nxtc Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
102558000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
198801000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
198672000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2483000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2372000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7778000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5567000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.797
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17930000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-16367000
us-gaap Net Income Loss
NetIncomeLoss
-52450000
us-gaap Net Income Loss
NetIncomeLoss
-21142000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27615038
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27547737
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27607685
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27524350
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.77
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4544382
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3149641
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0001558370-21-014632-index-headers.html Edgar Link pending
0001558370-21-014632-index.html Edgar Link pending
0001558370-21-014632.txt Edgar Link pending
0001558370-21-014632-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nxtc-20210930.xsd Edgar Link pending
nxtc-20210930x10q.htm Edgar Link pending
nxtc-20210930x10q_htm.xml Edgar Link completed
nxtc-20210930xex10d1.htm Edgar Link pending
nxtc-20210930xex31d1.htm Edgar Link pending
nxtc-20210930xex31d2.htm Edgar Link pending
nxtc-20210930xex32d1.htm Edgar Link pending
nxtc-20210930_cal.xml Edgar Link unprocessable
nxtc-20210930_def.xml Edgar Link unprocessable
nxtc-20210930_lab.xml Edgar Link unprocessable
nxtc-20210930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending